We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




AI-Powered Cervical Cell Analysis System Aids Early Cancer Detection

By LabMedica International staff writers
Posted on 27 Oct 2023
Print article
Image: The miLab Cartridge CER uses cervical cytology as a screening method (Photo courtesy of Noul)
Image: The miLab Cartridge CER uses cervical cytology as a screening method (Photo courtesy of Noul)

A novel cervical cell analysis product helps overcome the limitations of Human Papillomavirus (HPV) testing by offering detailed insights into the stages of cervical pre-cancer and cancer, using cervical cytology as a screening method.

Noul Co., Ltd. (Yongin, South Korea) launched its miLab Cartridge CER, a specialized device for automatically staining and evaluating cervical cells. The cervical cell analysis product works on samples from cervico-vaginal smears, either manually prepared or using liquid-based cytology (LBC). It employs the Papanicolaou staining method, enhanced by Next Generation Staining and Immunostaining (NGSI), a proprietary staining technology developed by Noul. When paired with Noul's AI-driven diagnostic system, miLab, it provides staining, imaging, and cellular analysis results that aid in making diagnostic decisions.

The miLab Cartridge CER leverages cervical cytology for screening and is capable of identifying the detailed stages of cervical pre-cancer and cancer. This is achieved through AI-based morphological analysis, a key advantage offered by the miLab platform. Additionally, the product speeds up the total time for testing, making it easier for users to survey the entire sample area, differentiate between cells that are negative or positive for cancer, and focus on the cells most relevant for diagnosis. Noul received the CE mark for the miLab Cartridge CER in August 2022 and the CE-IVDR certification for the miLab platform in February 2023.

"Through the launch of cervical cell analysis products, we have made a real step forward in the cancer diagnostic business,” said David Lim, CEO of Noul. “The miLab Cartridge CER is compatible with both PAP smear and LBC methods, and it enables efficient and accurate cervical cell review with the full automatic staining and analysis. We want to contribute to the early diagnosis of cervical cancer, the fourth largest cancer in the world for women."

Related Links:
Noul Co., Ltd. 

Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
C. difficile Toxins Test
SIMPLE GDH-Toxin

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Industry

view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.